tiprankstipranks
Incyte to hold a conference call
PremiumThe FlyIncyte to hold a conference call
1M ago
Incyte to hold a conference call
PremiumThe Fly
Incyte to hold a conference call
1M ago
Incyte announces new data from Phase 2 study evaluating ruxolitinib cream
PremiumThe Fly
Incyte announces new data from Phase 2 study evaluating ruxolitinib cream
1M ago
Incyte price target raised to $64 from $58 at BMO Capital
PremiumThe FlyIncyte price target raised to $64 from $58 at BMO Capital
2M ago
Incyte price target raised to $65 from $63 at RBC Capital
PremiumThe Fly
Incyte price target raised to $65 from $63 at RBC Capital
2M ago
Incyte price target raised to $68 from $67 at Stifel
PremiumThe Fly
Incyte price target raised to $68 from $67 at Stifel
2M ago
Incyte downgraded to Market Perform from Outperform at JMP Securities
PremiumThe FlyIncyte downgraded to Market Perform from Outperform at JMP Securities
2M ago
Early notable gainers among liquid option names on February 13th
PremiumThe Fly
Early notable gainers among liquid option names on February 13th
2M ago
Incyte reports Q4 EPS $1.06, consensus $1.16
PremiumThe Fly
Incyte reports Q4 EPS $1.06, consensus $1.16
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100